Itrasys 400mg Capsule contains an active component of Itraconazole. It is a potent antifungal agent utilised to combat diverse fungal infections in individuals. As a member of the triazole antifungal class, this medication demonstrates great efficacy against a wide spectrum of fungal species, making it a valuable therapeutic option against challenging mycoses. This medication operates by interrupting ergosterol synthesis, a critical component in the fungal cell membrane, thereby stopping the fungal growth and replication. It serves as a front-line treatment for superficial and systemic fungal infections. 

Its wide-ranging antifungal activity targets yeasts and moulds responsible for various conditions, from skin infections to invasive diseases. Itrasys 400mg Capsule treats fungal infections in nails, skin, mucous membranes, and systemic infections under specific circumstances. Regular liver function monitoring is essential during treatment. The medication is contraindicated in patients with known hypersensitivity to Itraconazole or its components. It should not be used during pregnancy and is not recommended during breastfeeding.

Itrasys 400mg Capsule treats the following:

• Superficial fungal infections (skin, nails, mucous membranes).
• Systemic fungal infections
• Onychomycosis (fungal nail infection)
• Vaginal candidiasis (yeast infection)
• Aspergillosis histoplasmosis
• Cryptococcosis
• Prophylaxis in immunocompromised patients
• Fungal pneumonia

Itraconazole exerts its therapeutic effects by inhibiting the synthesis of ergosterol, a vital component of the fungal cell membrane. This disruption weakens the membrane's integrity, contaminating essential cellular components and inhibiting fungal growth and replication. As a result, this medicine effectively treats various fungal infections, including superficial and systemic mycoses caused by susceptible fungi, relieving symptoms and promoting recovery in affected individuals.

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Itraconazole, reducing effectiveness by causing undesirable side effects.

• Store at room temperature, between 20°C to 25°C (68°F to 77°F).
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.

Itrasys 400mg Capsule is available in oral capsules. Your healthcare provider will determine the dosage of this medication based on your medical condition. It is crucial to adhere to their prescribed form and dosage for safe and effective treatment.

Itrasys 400mg Capsule causes some side effects like all medications, although not everyone will experience them. 

Serious:

• Jaundice
• Dark urine
• Allergic reactions (hives or swelling of the face, lips, tongue, or throat)

Common:

• Nausea.
• Vomiting
• Stomach pain
• Headache
• Dizziness
• Skin rash
• Muscle or joint pain
• Changes in taste sensation (dysgeusia)

Regular monitoring of liver function is crucial, particularly in individuals with pre-existing liver conditions or a history of liver disease, as the medication can cause liver toxicity. If you experience any signs of an allergic reaction, such as difficulty breathing or swelling, seek immediate medical attention. Additionally, Itraconazole may prolong the QT interval, leading to irregular heart rhythms, so patients with a history of heart rhythm disorders require close monitoring. For pregnant or breastfeeding individuals, it is essential to consult a healthcare provider before using this medication due to potential risks. Tendon disorders have been reported with this medication, so promptly report any tendon pain or inflammation to your healthcare provider. Elderly patients may be more susceptible to certain side effects, requiring close monitoring and potential dosage adjustments. By adhering to these precautions and communicating any concerns with your healthcare provider, you can ensure a safe and successful treatment experience with this medication.

1. Accord Healthcare Limited, Electronic Medicines Compendium (EMC), [Revised on Jan 2021] [Accessed on 26th Jul 2023], https://www.medicines.org.uk/emc/files/pil.5914.pdf 

2. KD Tripathi, Antifungal Drugs, Essentials of Medical Pharmacology, 8th Edition, 2019, 838-848.

3. Harry W. Lampiris, Daniel S. Maddix, Antifungal Agents, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 853-862.

4. S.H. Ibbotson, R.S. Dawe, Skin Disease, Davidson’s Principles and Practice of Medicine, 22nd Edition, 2014, 1249-1305.

5. Sanico N.V., FDA (Food and Drug Safety Administration)  [Revised on April 2001] [Accessed on 26th Jul 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022484s000lbl.pdf